10-Q 1 hqy-20211031.htm 10-Q hqy-20211031
00014283361/312022Q3FALSE00014283362021-02-012021-10-3100014283362021-11-30xbrli:shares00014283362021-10-31iso4217:USD00014283362021-01-31iso4217:USDxbrli:shares0001428336us-gaap:ServiceMember2021-08-012021-10-310001428336us-gaap:ServiceMember2020-08-012020-10-310001428336us-gaap:ServiceMember2021-02-012021-10-310001428336us-gaap:ServiceMember2020-02-012020-10-310001428336us-gaap:FinancialServiceOtherMember2021-08-012021-10-310001428336us-gaap:FinancialServiceOtherMember2020-08-012020-10-310001428336us-gaap:FinancialServiceOtherMember2021-02-012021-10-310001428336us-gaap:FinancialServiceOtherMember2020-02-012020-10-310001428336us-gaap:CreditAndDebitCardMember2021-08-012021-10-310001428336us-gaap:CreditAndDebitCardMember2020-08-012020-10-310001428336us-gaap:CreditAndDebitCardMember2021-02-012021-10-310001428336us-gaap:CreditAndDebitCardMember2020-02-012020-10-3100014283362021-08-012021-10-3100014283362020-08-012020-10-3100014283362020-02-012020-10-3100014283362021-07-3100014283362020-07-3100014283362020-01-310001428336us-gaap:CommonStockMember2021-07-310001428336us-gaap:CommonStockMember2020-07-310001428336us-gaap:CommonStockMember2021-01-310001428336us-gaap:CommonStockMember2020-01-310001428336us-gaap:CommonStockMember2020-02-012020-10-310001428336us-gaap:CommonStockMember2021-10-310001428336us-gaap:CommonStockMember2020-10-310001428336us-gaap:AdditionalPaidInCapitalMember2021-07-310001428336us-gaap:AdditionalPaidInCapitalMember2020-07-310001428336us-gaap:AdditionalPaidInCapitalMember2021-01-310001428336us-gaap:AdditionalPaidInCapitalMember2020-01-310001428336us-gaap:AdditionalPaidInCapitalMember2021-08-012021-10-310001428336us-gaap:AdditionalPaidInCapitalMember2020-08-012020-10-310001428336us-gaap:AdditionalPaidInCapitalMember2021-02-012021-10-310001428336us-gaap:AdditionalPaidInCapitalMember2020-02-012020-10-310001428336us-gaap:AdditionalPaidInCapitalMember2021-10-310001428336us-gaap:AdditionalPaidInCapitalMember2020-10-310001428336us-gaap:RetainedEarningsMember2021-07-310001428336us-gaap:RetainedEarningsMember2020-07-310001428336us-gaap:RetainedEarningsMember2021-01-310001428336us-gaap:RetainedEarningsMember2020-01-310001428336us-gaap:RetainedEarningsMember2021-08-012021-10-310001428336us-gaap:RetainedEarningsMember2020-08-012020-10-310001428336us-gaap:RetainedEarningsMember2021-02-012021-10-310001428336us-gaap:RetainedEarningsMember2020-02-012020-10-310001428336us-gaap:RetainedEarningsMember2021-10-310001428336us-gaap:RetainedEarningsMember2020-10-3100014283362020-10-310001428336us-gaap:ComputerSoftwareIntangibleAssetMember2021-02-012021-10-310001428336us-gaap:ComputerSoftwareIntangibleAssetMember2020-02-012020-10-310001428336hqy:AcquiredHSAIntangibleAssetsMember2021-02-012021-10-310001428336hqy:AcquiredHSAIntangibleAssetsMember2020-02-012020-10-310001428336hqy:FollowOnEquityOfferingMember2021-02-012021-04-300001428336hqy:FollowOnEquityOfferingMember2021-04-300001428336hqy:LuumAcquisitionMember2021-03-082021-03-080001428336hqy:LuumAcquisitionMember2021-03-08xbrli:pure0001428336hqy:FifthThirdBankHSAPortfolioAcquisitionMember2021-09-012021-09-290001428336hqy:LuumAcquisitionMember2021-08-012021-10-310001428336hqy:LuumAcquisitionMember2021-02-012021-10-310001428336hqy:LuumAcquisitionMember2021-10-310001428336hqy:LuumAcquisitionMember2021-03-082021-10-310001428336hqy:LuumAcquisitionMemberus-gaap:CustomerRelationshipsMember2021-03-082021-03-080001428336us-gaap:DevelopedTechnologyRightsMemberhqy:LuumAcquisitionMember2021-03-082021-03-080001428336hqy:LuumAcquisitionMemberus-gaap:TrademarksAndTradeNamesMember2021-03-082021-03-080001428336us-gaap:LeaseholdImprovementsMember2021-10-310001428336us-gaap:LeaseholdImprovementsMember2021-01-310001428336us-gaap:FurnitureAndFixturesMember2021-10-310001428336us-gaap:FurnitureAndFixturesMember2021-01-310001428336us-gaap:ComputerEquipmentMember2021-10-310001428336us-gaap:ComputerEquipmentMember2021-01-3100014283362021-11-012021-10-310001428336us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-10-310001428336us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2021-01-310001428336hqy:AcquiredHSAIntangibleAssetsMember2021-10-310001428336hqy:AcquiredHSAIntangibleAssetsMember2021-01-310001428336us-gaap:CustomerRelationshipsMember2021-10-310001428336us-gaap:CustomerRelationshipsMember2021-01-310001428336us-gaap:DevelopedTechnologyRightsMember2021-10-310001428336us-gaap:DevelopedTechnologyRightsMember2021-01-310001428336us-gaap:TradeNamesMember2021-10-310001428336us-gaap:TradeNamesMember2021-01-310001428336hqy:FifthThirdBankHealthSavingsAccountsPortfolioAcquisitionMember2021-09-29hqy:member0001428336hqy:A4500SeniorNotesDue2029Member2021-10-310001428336hqy:CreditAgreementMemberhqy:TermLoanFacilityMember2021-10-310001428336hqy:FurtherHealthSavingsAccountPortfolioAcquisitionMember2021-10-310001428336hqy:CreditAgreementMember2021-10-310001428336hqy:WageWorksInc.Member2021-04-300001428336hqy:UnionMesaMemberhqy:WageWorksInc.Memberus-gaap:SubsequentEventMember2021-11-240001428336hqy:WageWorksInc.Member2021-10-310001428336hqy:WageWorksInsurersMember2021-10-3100014283362018-09-062018-09-06hqy:lawsuit00014283362018-06-222018-06-220001428336hqy:A4500SeniorNotesDue2029Member2021-01-310001428336hqy:TermLoanFacilityMember2021-01-310001428336hqy:PriorCreditAgreementMemberhqy:TermLoanFacilityMember2021-10-310001428336hqy:PriorCreditAgreementMemberhqy:TermLoanFacilityMember2021-01-310001428336us-gaap:RevolvingCreditFacilityMember2021-10-310001428336us-gaap:RevolvingCreditFacilityMember2021-01-310001428336us-gaap:SeniorNotesMemberhqy:A4500SeniorNotesDue2029Member2021-10-080001428336us-gaap:SeniorNotesMemberhqy:A4500SeniorNotesDue2029Member2021-10-310001428336us-gaap:DebtInstrumentRedemptionPeriodOneMemberus-gaap:SeniorNotesMemberhqy:A4500SeniorNotesDue2029Member2021-10-082021-10-080001428336us-gaap:DebtInstrumentRedemptionPeriodTwoMemberus-gaap:SeniorNotesMemberhqy:A4500SeniorNotesDue2029Member2021-10-082021-10-080001428336us-gaap:DebtInstrumentRedemptionPeriodThreeMemberus-gaap:SeniorNotesMemberhqy:A4500SeniorNotesDue2029Member2021-10-082021-10-080001428336us-gaap:DebtInstrumentRedemptionPeriodFourMemberus-gaap:SeniorNotesMemberhqy:A4500SeniorNotesDue2029Member2021-10-082021-10-080001428336us-gaap:DebtInstrumentRedemptionPeriodFiveMemberus-gaap:SeniorNotesMemberhqy:A4500SeniorNotesDue2029Member2021-10-082021-10-080001428336hqy:CreditAgreementMemberus-gaap:SecuredDebtMemberhqy:TermLoanFacilityMember2021-10-082021-10-080001428336hqy:CreditAgreementMemberus-gaap:SecuredDebtMemberhqy:TermLoanFacilityMember2021-10-080001428336hqy:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-10-082021-10-080001428336hqy:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-10-080001428336hqy:CreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LetterOfCreditMember2021-10-080001428336hqy:CreditAgreementMember2021-10-080001428336srt:MinimumMemberhqy:CreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMember2021-10-082021-10-080001428336hqy:CreditAgreementMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MaximumMember2021-10-082021-10-080001428336srt:MinimumMemberhqy:CreditAgreementMemberus-gaap:BaseRateMember2021-10-082021-10-080001428336hqy:CreditAgreementMemberus-gaap:BaseRateMembersrt:MaximumMember2021-10-082021-10-080001428336srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-02-012021-10-310001428336us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMembersrt:MaximumMember2021-02-012021-10-310001428336hqy:CreditAgreementMemberus-gaap:LineOfCreditMemberhqy:DebtInstrumentAmortizationPeriodOneMemberhqy:TermLoanFacilityMember2021-10-310001428336hqy:CreditAgreementMemberus-gaap:LineOfCreditMemberhqy:DebtInstrumentAmortizationPeriodTwoAndThreePeriodMemberhqy:TermLoanFacilityMember2021-10-310001428336hqy:CreditAgreementMemberus-gaap:LineOfCreditMemberhqy:DebtInstrumentAmortizationPeriodFourMemberhqy:TermLoanFacilityMember2021-10-310001428336hqy:CreditAgreementMemberus-gaap:LineOfCreditMemberhqy:DebtInstrumentAmortizationPeriodFiveMemberhqy:TermLoanFacilityMember2021-10-310001428336hqy:CreditAgreementMemberus-gaap:LineOfCreditMemberhqy:TermLoanFacilityMember2021-10-310001428336hqy:CreditAgreementMemberus-gaap:LineOfCreditMemberhqy:TermLoanFacilityMember2021-02-012021-10-310001428336hqy:PriorCreditAgreementMemberus-gaap:SecuredDebtMemberhqy:TermLoanFacilityMember2019-08-302019-08-300001428336hqy:PriorCreditAgreementMemberus-gaap:SecuredDebtMemberhqy:TermLoanFacilityMember2019-08-300001428336us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhqy:PriorCreditAgreementMember2019-08-302019-08-300001428336us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhqy:PriorCreditAgreementMember2019-08-300001428336srt:MinimumMemberus-gaap:LondonInterbankOfferedRateLIBORMemberhqy:PriorCreditAgreementMember2019-08-302019-08-300001428336us-gaap:LondonInterbankOfferedRateLIBORMemberhqy:PriorCreditAgreementMembersrt:MaximumMember2019-08-302019-08-300001428336srt:MinimumMemberus-gaap:BaseRateMemberhqy:PriorCreditAgreementMember2019-08-302019-08-300001428336us-gaap:BaseRateMemberhqy:PriorCreditAgreementMembersrt:MaximumMember2019-08-302019-08-300001428336srt:MinimumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhqy:PriorCreditAgreementMember2019-08-302019-08-300001428336us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberhqy:PriorCreditAgreementMembersrt:MaximumMember2019-08-302019-08-300001428336hqy:PriorCreditAgreementMemberhqy:DebtCovenantPeriodOneMember2019-08-300001428336hqy:PriorCreditAgreementMemberhqy:DebtCovenantPeriodTwoMember2019-08-300001428336hqy:PriorCreditAgreementMember2019-08-302019-08-300001428336hqy:PriorCreditAgreementMember2019-08-300001428336us-gaap:CostOfSalesMember2021-08-012021-10-310001428336us-gaap:CostOfSalesMember2020-08-012020-10-310001428336us-gaap:CostOfSalesMember2021-02-012021-10-310001428336us-gaap:CostOfSalesMember2020-02-012020-10-310001428336hqy:SalesandMarketingMember2021-08-012021-10-310001428336hqy:SalesandMarketingMember2020-08-012020-10-310001428336hqy:SalesandMarketingMember2021-02-012021-10-310001428336hqy:SalesandMarketingMember2020-02-012020-10-310001428336hqy:TechnologyandDevelopmentMember2021-08-012021-10-310001428336hqy:TechnologyandDevelopmentMember2020-08-012020-10-310001428336hqy:TechnologyandDevelopmentMember2021-02-012021-10-310001428336hqy:TechnologyandDevelopmentMember2020-02-012020-10-310001428336us-gaap:GeneralAndAdministrativeExpenseMember2021-08-012021-10-310001428336us-gaap:GeneralAndAdministrativeExpenseMember2020-08-012020-10-310001428336us-gaap:GeneralAndAdministrativeExpenseMember2021-02-012021-10-310001428336us-gaap:GeneralAndAdministrativeExpenseMember2020-02-012020-10-310001428336us-gaap:OtherExpenseMember2021-08-012021-10-310001428336us-gaap:OtherExpenseMember2020-08-012020-10-310001428336us-gaap:OtherExpenseMember2021-02-012021-10-310001428336us-gaap:OtherExpenseMember2020-02-012020-10-310001428336hqy:IncentivePlanMember2021-10-3100014283362021-02-012021-04-300001428336us-gaap:RestrictedStockUnitsRSUMember2021-01-310001428336us-gaap:RestrictedStockMember2021-01-310001428336us-gaap:RestrictedStockUnitsRSUMember2021-02-012021-10-310001428336us-gaap:RestrictedStockMember2021-02-012021-10-310001428336us-gaap:RestrictedStockUnitsRSUMember2021-10-310001428336us-gaap:RestrictedStockMember2021-10-310001428336hqy:PerformanceRestrictedStockUnitsMember2021-02-012021-04-300001428336hqy:PerformanceRestrictedStockUnitsMember2021-04-300001428336srt:MinimumMemberhqy:PerformanceRestrictedStockUnitsMember2021-02-012021-10-310001428336hqy:PerformanceRestrictedStockUnitsMembersrt:MaximumMember2021-02-012021-10-310001428336us-gaap:FairValueInputsLevel2Memberhqy:A4500SeniorNotesDue2029Member2021-10-310001428336us-gaap:FairValueInputsLevel3Member2021-10-310001428336hqy:ContingentConsiderationMember2021-01-310001428336hqy:ContingentConsiderationMember2021-02-012021-10-310001428336hqy:ContingentConsiderationMember2021-10-310001428336hqy:FurtherHealthSavingsAccountPortfolioAcquisitionMember2021-04-012021-04-300001428336hqy:FurtherHealthSavingsAccountPortfolioAcquisitionMember2021-04-300001428336hqy:FurtherHealthSavingsAccountPortfolioAcquisitionMember2021-09-012021-09-300001428336hqy:HealthSavingsAdministratorsLLCMemberus-gaap:SubsequentEventMember2021-12-062021-12-060001428336hqy:HealthSavingsAdministratorsLLCMemberus-gaap:SubsequentEventMember2021-12-06



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


Form 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 31, 2021
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission file number: 001-36568
HEALTHEQUITY, INC.
(Exact name of registrant as specified in its charter)
Delaware52-2383166
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification Number)
15 West Scenic Pointe Drive
Suite 100
Draper, Utah 84020
(Address of principal executive offices) (Zip code)

(801) 727-1000
(Registrant's telephone Number, including Area Code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stock, par value $0.0001 per shareHQYThe NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
 Emerging growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of November 30, 2021, there were 83,601,381 shares of the registrant's common stock outstanding.



HealthEquity, Inc. and subsidiaries
Form 10-Q quarterly report

Table of contents
Page
Part I. FINANCIAL INFORMATION
Item 1.
Item 2.
Item 3.
Item 4.
Part II. OTHER INFORMATION
Item 1.
Item 1A.
Item 6.


-2-


Part I. Financial information
Item 1. Financial statements

HealthEquity, Inc. and subsidiaries
Condensed consolidated balance sheets
(in thousands, except par value)October 31, 2021January 31, 2021
(unaudited)
Assets
Current assets
Cash and cash equivalents$649,129 $328,803 
Accounts receivable, net of allowance for doubtful accounts of $6,063 and $4,239 as of October 31, 2021 and January 31, 2021, respectively
84,083 72,767 
Other current assets30,919 58,607 
Total current assets764,131 460,177 
Property and equipment, net24,930 29,106 
Operating lease right-of-use assets81,150 89,508 
Intangible assets, net820,946 767,003 
Goodwill1,363,549 1,327,193 
Other assets44,908 37,420 
Total assets$3,099,614 $2,710,407 
Liabilities and stockholders’ equity
Current liabilities
Accounts payable$5,244 $1,614 
Accrued compensation32,695 50,670 
Accrued liabilities49,879 75,880 
Current portion of long-term debt6,563 62,500 
Operating lease liabilities12,693 14,037 
Total current liabilities107,074 204,701 
Long-term liabilities
Long-term debt, net923,501 924,217 
Operating lease liabilities, non-current67,836 74,224 
Other long-term liabilities18,953 8,808 
Deferred tax liability110,400 119,729 
Total long-term liabilities1,120,690 1,126,978 
Total liabilities1,227,764 1,331,679 
Commitments and contingencies (see Note 6)
Stockholders’ equity
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of October 31, 2021 and January 31, 2021, respectively
  
Common stock, $0.0001 par value, 900,000 shares authorized, 83,586 and 77,168 shares issued and outstanding as of October 31, 2021 and January 31, 2021, respectively
8 8 
Additional paid-in capital1,662,965 1,158,372 
Accumulated earnings208,877 220,348 
Total stockholders’ equity1,871,850 1,378,728 
Total liabilities and stockholders’ equity$3,099,614 $2,710,407 
See accompanying notes to condensed consolidated financial statements.

-3-


HealthEquity, Inc. and subsidiaries
Condensed consolidated statements of operations and
comprehensive income (loss) (unaudited)
Three months ended October 31,Nine months ended October 31,
(in thousands, except per share data)2021202020212020
Revenue
Service revenue$102,733 $104,562 $314,449 $319,638 
Custodial revenue49,006 48,544 144,760 142,352 
Interchange revenue28,215 26,245 94,050 83,411 
Total revenue179,954 179,351 553,259 545,401 
Cost of revenue
Service costs66,217 65,936 204,183 202,195 
Custodial costs5,734 4,762 15,567 14,805 
Interchange costs4,683 4,095 15,102 13,985 
Total cost of revenue76,634 74,793 234,852 230,985 
Gross profit103,320 104,558 318,407 314,416 
Operating expenses
Sales and marketing12,726 12,880 42,288 36,502 
Technology and development38,070 30,758 111,437 92,490 
General and administrative20,004 22,099 63,503 61,590 
Amortization of acquired intangible assets19,642 19,126 59,745 56,905 
Merger integration13,244 8,193 38,422 31,328 
Total operating expenses103,686 93,056 315,395 278,815 
Income (loss) from operations(366)11,502 3,012 35,601 
Other expense
Interest expense(11,881)(6,952)(25,824)(28,110)
Other income (expense), net3,122 (421)(164)(2,009)
Total other expense(8,759)(7,373)(25,988)(30,119)
Income (loss) before income taxes(9,125)4,129 (22,976)5,482 
Income tax provision (benefit)(4,087)2,340 (11,505)2,015 
Net income (loss) and comprehensive income (loss)$(5,038)$1,789 $(11,471)$3,467 
Net income (loss) per share:
Basic$(0.06)$0.02 $(0.14)$0.05 
Diluted$(0.06)$0.02 $(0.14)$0.05 
Weighted-average number of shares used in computing net income (loss) per share:
Basic83,551 76,701 82,939 73,358 
Diluted83,551 77,845 82,939 74,665 
See accompanying notes to condensed consolidated financial statements.
-4-


HealthEquity, Inc. and subsidiaries
Condensed consolidated statements of stockholders’ equity (unaudited)
Three months ended October 31,Nine months ended October 31,
(in thousands)2021202020212020
Total stockholders' equity, beginning balance$1,862,666 $1,340,336 $1,378,728 $1,030,295 
Common stock:
Beginning balance8 8 8 7 
Issuance of common stock upon exercise of stock options, and for restricted stock— — — — 
Other issuance of common stock— — — 1 
Ending balance8 8 8 8 
Additional paid-in capital:
Beginning balance1,648,743 1,127,136 1,158,372 818,774 
Issuance of common stock upon exercise of stock options, and for restricted stock938 1,651 6,253 4,402 
Other issuance of common stock— 2 456,640 286,779 
Stock-based compensation13,284 11,479 41,700 30,313 
Ending balance1,662,965 1,140,268 1,662,965 1,140,268 
Accumulated earnings
Beginning balance213,915 213,192 220,348 211,514 
Net income (loss)(5,038)1,789 (11,471)3,467 
Ending balance208,877 214,981 208,877 214,981 
Total stockholders' equity, ending balance$1,871,850 $1,355,257 $1,871,850 $1,355,257 
See accompanying notes to condensed consolidated financial statements.

-5-


HealthEquity, Inc. and subsidiaries
Condensed consolidated statements of cash flows (unaudited)
Nine months ended October 31,
(in thousands)20212020
Cash flows from operating activities:
Net income (loss)$(11,471)$3,467 
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization98,364 85,485 
Stock-based compensation41,700 30,313 
Amortization of debt discount and issuance costs3,616 3,818 
Loss on extinguishment of debt4,044  
Change in fair value of contingent consideration(2,147) 
Other non-cash items(750)1,727 
Deferred taxes(8,765)(973)
Changes in operating assets and liabilities:
Accounts receivable, net(10,090)8,063 
Other assets19,888 3,309 
Operating lease right-of-use assets8,944 8,344 
Accrued compensation(18,098)(15,251)
Accounts payable, accrued liabilities, and other current liabilities(34,023)(7,936)
Operating lease liabilities, non-current(6,808)(8,361)
Other long-term liabilities6,034 8,712 
Net cash provided by operating activities90,438 120,717 
Cash flows from investing activities:
Acquisitions, net of cash acquired(49,533) 
Purchases of software and capitalized software development costs(49,033)(37,242)
Purchases of property and equipment(7,284)(11,388)
Acquisition of intangible member assets(64,463)(28,100)
Proceeds from sale of equity securities2,367  
Net cash used in investing activities(167,946)(76,730)
Cash flows from financing activities:
Principal payments on long-term debt(1,003,125)(223,438)
Proceeds from issuance of long-term debt950,000  
Payment of debt issuance costs(11,846) 
Proceeds from follow-on equity offering, net of payments for offering costs456,642 286,779 
Settlement of client-held funds obligation, net(1,565)(4,189)
Proceeds from exercise of common stock options7,728 4,491 
Net cash provided by financing activities397,834 63,643 
Increase in cash and cash equivalents320,326 107,630 
Beginning cash and cash equivalents328,803 191,726 
Ending cash and cash equivalents$649,129 $299,356 
See accompanying notes to condensed consolidated financial statements.
-6-


HealthEquity, Inc. and subsidiaries
Condensed consolidated statements of cash flows (unaudited) (continued)
Nine months ended October 31,
(in thousands)20212020
Supplemental cash flow data:
Interest expense paid in cash$13,685 $22,849 
Income tax payments (refunds), net(5,926)1,053 
Supplemental disclosures of non-cash investing and financing activities:
Purchases of software and capitalized software development costs included in accounts payable, accrued liabilities, or accrued compensation3,708 1,346 
Purchases of property and equipment included in accounts payable or accrued liabilities479 167 
Purchases of intangible member assets included in accounts payable or accrued liabilities2,281 289 
Contingent consideration recognized at acquisition8,147  
Exercise of common stock options receivable1 89 
Decrease in goodwill due to measurement period adjustments, net19 5,838 
See accompanying notes to condensed consolidated financial statements.
-7-


HealthEquity, Inc. and subsidiaries
Notes to condensed consolidated financial statements
Note 1. Summary of business and significant accounting policies
Business
HealthEquity, Inc. ("HealthEquity" or the "Company") was incorporated in the state of Delaware on September 18, 2002. HealthEquity is a leader in administering health savings accounts (“HSAs”) and complementary consumer-directed benefits (“CDBs”), which empower consumers to access tax-advantaged healthcare savings while also providing corporate tax advantages for employers.
Principles of consolidation
The condensed consolidated financial statements include the accounts of HealthEquity and its direct and indirect subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Basis of presentation
The accompanying condensed consolidated financial statements as of October 31, 2021 and for the three and nine months ended October 31, 2021 and 2020 are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP") and the applicable rules and regulations of the Securities and Exchange Commission ("SEC") regarding interim financial reporting. In the opinion of management, the interim data includes all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results for the interim periods. Certain information and note disclosures normally included in annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the fiscal year ended January 31, 2021. The fiscal year-end condensed consolidated balance sheet data was derived from audited financial statements, but does not include all disclosures required by GAAP.
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
Follow-on equity offering
In the first quarter of fiscal year 2022, the Company closed a follow-on public offering of 5,750,000 shares of common stock at a public offering price of $80.30 per share, less the underwriters' discount. The Company received net proceeds of $456.6 million after deducting underwriting discounts and commissions of $4.6 million and other offering expenses of approximately $0.5 million. The Company used $50.2 million of the net proceeds from the offering to acquire 100% of the outstanding capital stock of Fort Effect Corp, d/b/a Luum, and used an additional $60.8 million to acquire the Fifth Third Bank HSA portfolio. The Company used the remaining net proceeds from the offering, and other cash on hand, for the acquisition of Further on November 1, 2021. For a description of the Further acquisition, refer to Note 11—Subsequent events.
Significant accounting policies
There have been no material changes in the Company’s significant accounting policies as compared to the significant accounting policies described in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2021.
Recently adopted accounting pronouncements
None.
Recently issued accounting pronouncements not yet adopted
None.
-8-

Table of Contents


Note 2. Net income (loss) per share
The following table sets forth the computation of basic and diluted net income (loss) per share:
Three months ended October 31,Nine months ended October 31,
(in thousands, except per share data)2021202020212020
Numerator (basic and diluted):
Net income (loss)$(5,038)$1,789 $(11,471)$3,467 
Denominator (basic):
Weighted-average common shares outstanding83,551 76,701 82,939 73,358 
Denominator (diluted):
Weighted-average common shares outstanding83,551 76,701 82,939 73,358 
Weighted-average dilutive effect of stock options and restricted stock units 1,144  1,307 
Diluted weighted-average common shares outstanding83,551 77,845 82,939 74,665 
Net income (loss) per share:
Basic $(0.06)$0.02 $(0.14)$0.05 
Diluted$(0.06)$0.02 $(0.14)$0.05 
For the three months ended October 31, 2021 and 2020, 1.6 million and 1.0 million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.
For the nine months ended October 31, 2021 and 2020, approximately 1.9 million and 0.6 million shares, respectively, attributable to stock options and restricted stock units were excluded from the calculation of diluted earnings per share as their inclusion would have been anti-dilutive.
Note 3. Business combination
Acquisition of Luum
On March 8, 2021, the Company acquired 100% of the outstanding capital stock of Fort Effect Corp, d/b/a Luum (the "Luum Acquisition"). Luum provides employers with a suite of commute tools as well as real-time commute data to help them design and implement flexible return-to-office and hybrid-workplace strategies and benefits. The aggregate purchase price consisted of $50.2 million in cash, and up to $20.0 million in additional payments which were contingent on Luum achieving certain revenue targets during the two-year period following the closing of the Luum Acquisition and, if achieved, would be payable in fiscal years 2023 and 2024. The Company recorded an $8.1 million liability representing its best estimate of the fair value of the contingent consideration as of the acquisition date. The fair value of this contingent consideration was determined using a Monte Carlo valuation model based on Level 3 inputs, with any changes in the fair value recorded as other income (expense), net, in the condensed consolidated statement of operations and comprehensive income (loss). During the three and nine months ended October 31, 2021, the Company recognized income of $3.2 million and $2.1 million, respectively, resulting from changes in the fair value of the contingent consideration. On October 31, 2021, the Company entered into an amendment to the purchase agreement to pay $6.0 million in satisfaction of the contingent consideration liability, which is presented within accrued liabilities on the Company's condensed consolidated balance sheet as of October 31, 2021.
The Luum Acquisition was accounted for under the acquisition method of accounting for business combinations. Consideration paid was allocated to the tangible and intangible assets acquired and liabilities assumed based on their fair values as of the acquisition date. The initial allocation of the consideration paid was based on a preliminary valuation and is subject to adjustment during the measurement period (up to one year from the acquisition date). Balances subject to adjustment primarily include the valuations of acquired assets (tangible and intangible) and liabilities assumed, as well as tax-related matters. The Company expects the allocation of the consideration transferred to be finalized within the measurement period.
-9-

Table of Contents


The following table summarizes the Company's current allocation of the consideration paid:
(in thousands)Estimated fair valueAdjustmentsUpdated Allocation
Cash and cash equivalents$626 $— $626 
Other current assets1,469 — 1,469 
Intangible assets23,900 — 23,900 
Goodwill36,374 (19)36,355 
Other assets100 — 100 
Current liabilities(597)— (597)
Deferred tax liability(3,566)19 (3,547)
Total consideration paid$58,306 $ $58,306 
The Luum Acquisition resulted in $36.4 million of goodwill. The preliminary goodwill to be recognized is attributable to several strategic, operational, and financial benefits expected from the Luum Acquisition, including an expanded commuter offering beyond traditional pre-tax commuter benefits and additional cross-selling opportunities. The adjustments to the initial allocation were based on more detailed information obtained about the specific assets acquired, liabilities assumed, and tax-related matters. The goodwill created in the Luum Acquisition is not expected to be deductible for tax purposes.
The preliminary allocation of consideration exchanged to acquired identified intangible assets is as follows:
($ in thousands)Fair valueEstimated life
(in years)
Customer relationships (1)$12,400 7.0
Developed technology (1)10,900 5.0
Trade names & trademarks (1)600 3.0
Total acquired intangible assets$23,900 6.0
(1) The Company preliminarily valued the acquired assets utilizing the discounted cash flow method, a form of the income approach.

The pro forma effects of the Luum Acquisition would not materially impact the Company's reported results for any period presented, and as a result no pro forma financial information is presented.
Note 4. Supplemental financial statement information
Selected condensed consolidated balance sheet and condensed consolidated statement of operations and comprehensive income (loss) components consisted of the following:
Property and equipment
Property and equipment consisted of the following as of October 31, 2021 and January 31, 2021:
(in thousands)October 31, 2021January 31, 2021
Leasehold improvements$20,718 $22,271 
Furniture and fixtures9,068 9,230 
Computer equipment34,099 28,592 
Property and equipment, gross63,885 60,093 
Accumulated depreciation(38,955)(30,987)
Property and equipment, net$24,930 $29,106 
Depreciation expense for the three months ended October 31, 2021 and 2020 was $3.5 million and $4.0 million, respectively, and $10.9 million and $12.0 million for the nine months ended October 31, 2021 and 2020, respectively.
Contract balances
The Company does not recognize revenue until its right to consideration is unconditional and therefore has no related contract assets. The Company records a receivable when revenue is recognized prior to payment and the Company has unconditional right to payment. Alternatively, when payment precedes the related services, the Company records a contract liability, or deferred revenue, until its performance obligations are satisfied. As of
-10-

October 31, 2021 and January 31, 2021, the balance of deferred revenue was $10.1 million and $4.1 million, respectively. The balances are related to cash received in advance for interchange and custodial revenue arrangements, other up-front fees and other commuter deferred revenue. The Company expects to recognize approximately 40% of its balance of deferred revenue as revenue over the next 12 months and the remainder thereafter. During the three and nine months ended October 31, 2021, approximately $0.3 million and $1.4 million of revenue was recognized that was included in the balance of deferred revenue as of January 31, 2021.
Leases
The components of operating lease costs were as follows:
Three months ended October 31,Nine months ended October 31,
(in thousands)
2021202020212020
Operating lease expense$3,512 $3,777 $11,322 $12,297 
Sublease income(455)(450)(1,355)(1,349)
Net operating lease expense$3,057 $3,327 $9,967 $10,948 
Other income (expense), net
Other income (expense), net, consisted of the following:
Three months ended October 31,Nine months ended October 31,
(in thousands)2021202020212020
Interest income$478 $174 $1,419 $850 
Gain on equity securities  1,677  
Acquisition gains (costs), net2,687 (13)(4,917)(79)
Other income (expense), net(43)(582)1,657 (2,780)
Total other income (expense), net$3,122 $(421)$(164)$(2,009)
Interest expense
Based on the application of Accounting Standards Codification ("ASC") 470-50, Debt - Modifications and Extinguishments, the Company recorded a $4.0 million loss on extinguishment of debt during the three months ended October 31, 2021, which is included within interest expense in the condensed consolidated statements of operations and comprehensive income (loss) for the three and nine months ended October 31, 2021.
Supplemental cash flow information
Supplemental cash flow information related to the Company's operating leases was as follows:
Nine months ended October 31,
(in thousands)20212020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$10,928 $9,739 
Operating lease right-of-use assets obtained in exchange for new operating lease obligations$586 $17,480 





-11-

Table of Contents
Note 5. Intangible assets and goodwill
Intangible assets
The gross carrying amount and associated accumulated amortization of intangible assets were as follows as of October 31, 2021 and January 31, 2021:
(in thousands)October 31, 2021January 31, 2021
Amortizable intangible assets:
Software and software development costs$177,693 $127,005 
Acquired HSA portfolios191,885 125,141 
Acquired customer relationships613,781 601,381 
Acquired developed technology107,825 96,925 
Acquired trade names12,900 12,300 
Amortizable intangible assets, gross1,104,084 962,752 
Accumulated amortization(283,138)(195,749)
Amortizable intangible assets, net$820,946 $767,003 
Amortization expense for the three months ended October 31, 2021 and 2020 was $30.0 million and $25.3 million, respectively, and $87.5 million and $73.5 million for the nine months ended October 31, 2021 and 2020, respectively.
Fifth Third Bank HSA portfolio acquisition. In April 2021, the Company entered into a definitive agreement with Fifth Third Bank, National Association ("Fifth Third"), to transition the custody of Fifth Third’s HSA portfolio to HealthEquity. On September 29, 2021, the transaction was closed, in which the Company paid a $60.8 million purchase price for a transfer of approximately 160,000 HSAs and $491.0 million of HSA Assets. The agreement includes a mechanism to adjust the purchase price based on the amount of HSA Assets actually transferred.
Goodwill
During the nine months ended October 31, 2021, goodwill increased by $36.4 million due to the Luum Acquisition. For further information, see Note 3—Business combination. There were no other changes to the carrying value of goodwill during the nine months ended October 31, 2021.
Note 6. Commitments and contingencies
Commitments
The following table summarizes the payments due by fiscal year for our outstanding contractual obligations as of October 31, 2021:
Payments due by fiscal year
(in thousands)20222023202420252026ThereafterTotal
4.50% Senior Notes due 2029 (1)
$ $ $ $ $ $600,000 $600,000 
Term Loan Facility (1) 8,750 17,500 17,500 26,250 280,000 350,000 
Interest on long-term debt obligations (2)8,577 33,951 33,708 33,467 32,965 103,739 246,407 
Operating lease obligations (3)3,416 12,689 10,442 10,836 11,080 52,563 101,026 
Further acquisition (4)500,000      500,000 
Contingent acquisition consideration6,000      6,000 
Other contractual obligations (5)7,143 21,368 9,559 622 16  38,708 
Total$525,136 $76,758 $71,209 $62,425 $70,311 $1,036,302 $1,842,141 
(1)As of October 31, 2021, our outstanding combined principal of $950.0 million is presented net of debt discount and issuance costs on our condensed consolidated balance sheets. The debt discount and issuance costs are not included in the table above.
(2)With respect to the Term Loan Facility, estimated interest payments assume the stated interest rate applicable as of October 31, 2021 of 1.88% per annum.
(3)We lease office space and data storage facilities, and we have other non-cancelable operating leases expiring at various dates through 2031. These amounts exclude contractual sublease income of $2.7 million, which is expected to be received through March 2023.
(4)For a description of the Further acquisition, refer to Note 11—Subsequent events.
(5)Other contractual obligations consist of processing services agreements, telephony services, and other contractual commitments.
-12-

Table of Contents

Contingencies
In the normal course of business, the Company enters into contracts and agreements that contain a variety of covenants, representations, and warranties and provide for general indemnifications. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but have not yet been made. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.
Legal matters
In April 2021, WageWorks exercised its right to terminate a lease for office space in Mesa, Arizona that had not yet commenced, with aggregate lease payments of $63.1 million and a term of approximately 11 years, following the landlord's failure to fulfill its obligations under the lease agreement. Because the lease had not yet commenced, the Company had not recognized a right-of-use asset, operating lease liability, or any rent expense associated with the lease. WageWorks' right to terminate the lease agreement was disputed by the landlord, Union Mesa 1, LLC (“Union Mesa”). On November 5, 2021, Union Mesa notified WageWorks that it was in default of the lease for failure to pay rent, which Union Mesa claimed was due beginning in November 2021, and on November 24, 2021 drew $2.8 million, the full amount under the letter of credit that WageWorks had posted to secure its obligations under the lease. On December 1, 2021, WageWorks filed a lawsuit against Union Mesa in the Superior Court of the State of Arizona in and for the County of Maricopa. Pursuant to the lawsuit, WageWorks seeks declaratory judgment that the lease was properly terminated and recourse against Union Mesa for breach of contract, breach of the duty of good faith and fair dealing, and conversion, including return of the funds drawn under the letter of credit.
On March 9, 2018, a putative class action was filed in the U.S. District Court for the Northern District of California (the “Securities Class Action”). On May 16, 2019, a consolidated amended complaint was filed by the lead plaintiffs asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, against the Company's subsidiary WageWorks, Inc. ("WageWorks"), its former Chief Executive Officer and its former Chief Financial Officer on behalf of purchasers of WageWorks common stock between May 6, 2016 and March 1, 2018. The complaint also alleged claims under the Securities Act of 1933, as amended, arising from WageWorks’ June 19, 2017 common stock offering against those same defendants, as well as the members of its board of directors at the time of that offering. The class action settled for $30.0 million. During the nine months ended October 31, 2021, WageWorks contributed $5.0 million and its insurers paid the remaining $25.0 million. The court granted final approval of the settlement and entered a final judgment on August 20, 2021. This matter is now closed.
On June 22, 2018 and September 6, 2018, two derivative lawsuits were filed against certain of WageWorks’ former officers and directors and WageWorks (as nominal defendant) in the Superior Court of the State of California, County of San Mateo. The actions were consolidated. On July 23, 2018, a similar derivative lawsuit was filed against certain former WageWorks’ officers and directors and WageWorks (as nominal defendant) in the U.S. District Court for the Northern District of California (together, the “Derivative Suits”). The allegations in the Derivative Suits relate to substantially the same facts as those underlying the Securities Class Action described above. The plaintiffs seek unspecified damages, fees and costs. Plaintiffs in the Superior Court action filed an amended consolidated complaint on October 28, 2019, naming as defendants certain former officers and directors of WageWorks and alleging a direct claim of "inseparable fraud/breach of fiduciary duty" on behalf of a class. WageWorks was not named as a party in that complaint. On June 24, 2020, the court granted the defendants’ motion to dismiss the amended complaint. The plaintiffs subsequently filed a notice of appeal. On October 28, 2021, the court of appeal dismissed the appeal pursuant to the release in the class action settlement discussed above. The District Court action is currently stayed.
WageWorks previously entered into indemnification agreements with its former directors and officers and, pursuant to these indemnification agreements, is covering the defense fees and costs of its former directors and officers in the legal proceedings described above.
The Company and its subsidiaries are involved in various other litigation, governmental proceedings and claims, not described above, that arise in the normal course of business. It is not possible to determine the ultimate outcome or the duration of such litigation, governmental proceedings or claims, or the impact that such litigation, proceedings and claims will have on the Company’s financial position, results of operations, and cash flows.
As required under GAAP, the Company records a provision for contingent losses when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company does not believe, based on currently available information, that any liabilities relating to these matters are probable or that the amount of any resulting loss is estimable. However, litigation is subject to inherent uncertainties and the Company’s view of these matters may change in the future. Were an unfavorable outcome to occur, there exists the possibility of a
-13-

Table of Contents

material adverse impact on the Company’s financial position, results of operations and cash flows for the period in which the unfavorable outcome occurs, and potentially in future periods.
Note 7. Income taxes
The Company follows ASC 740-270, Income Taxes - Interim Reporting, for the computation and presentation of its interim period tax provision. Accordingly, management estimated the effective annual tax rate and applied this rate to the year-to-date pre-tax book income (loss) to determine the interim benefit or provision for income taxes. For the three and nine months ended October 31, 2021, the Company recorded an income tax benefit of $4.1 million and $11.5 million, respectively. This resulted in an effective income tax benefit rate of 44.8% and 50.1% for the three and nine months ended October 31, 2021, respectively, compared with an effective income tax expense rate of 56.7% and 36.8% for the three and nine months ended October 31, 2020, respectively. For the three and nine months ended October 31, 2021, discrete tax items had an effective tax rate benefit of 7.7% and 20.5%, respectively, compared with an effective tax rate expense of 6.0% and an effective tax rate benefit of 9.6% for the three and nine months ended October 31, 2020, respectively, primarily due to excess tax benefits on stock-based compensation expense recognized in the provision for income taxes.
As of October 31, 2021 and January 31, 2021, the Company’s total gross unrecognized tax benefit was $11.2 million and $10.2 million, respectively. If recognized, $10.3 million of the total gross unrecognized tax benefits would affect the Company's effective tax rate as of October 31, 2021.
The Company files income tax returns with U.S. federal and state taxing jurisdictions and is currently under examination by the IRS and in the state of Texas. These examinations may lead to ordinary course adjustments or proposed adjustments to our taxes, net operating losses, and/or tax credit carryforwards. As a result of the Company's net operating loss carryforwards and tax credit carryforwards, the Company remains subject to examination by one or more jurisdictions for tax years after 2001.
Note 8. Indebtedness
Long-term debt consisted of the following:
(in thousands)October 31, 2021January 31, 2021
4.50% Senior Notes due 2029
$600,000 $ 
Term Loan Facility350,000  
Prior Term Loan Facility 1,003,125 
Principal amount950,000 1,003,125 
Less: unamortized discount and issuance costs (1)19,936 16,408 
Total debt, net930,064 986,717 
Less: current portion of long-term debt6,56362,500
Long-term debt, net$923,501 $924,217 
(1)In addition to the $19.9 million and $16.4 million of unamortized discount and issuance costs related to long-term debt as of October 31, 2021 and January 31, 2021, respectively, $4.6 million and $5.0 million of unamortized issuance costs related to our Revolving Credit Facility (as defined below) and Prior Revolving Credit Facility (as defined below) are included within other assets on the condensed consolidated balance sheets as of October 31, 2021 and January 31, 2021, respectively.
4.50% Senior Notes due 2029
On October 8, 2021, the Company completed its offering of $600.0 million aggregate principal amount of its 4.50% Senior Notes due 2029 (the “Notes”). The Notes were issued under an indenture (the “Indenture”), dated October 8, 2021, among the Company, the guarantors party thereto, and Wells Fargo Bank, National Association, as trustee.
The net proceeds from the issuance of the Notes together with borrowings under the Credit Agreement (as defined below) and cash on hand, were used to repay the outstanding borrowings under the Prior Credit Agreement (as defined below).
The Notes are guaranteed by each of the Company’s existing direct and indirect, wholly owned domestic subsidiaries that guarantees its obligations under the Credit Agreement and are required to be guaranteed by any of the Company’s future subsidiaries that guarantee its obligations under the Credit Agreement or certain of its other indebtedness. The Notes will mature on October 1, 2029. Interest on the Notes will be payable on April 1 and October 1 of each year, beginning on April 1, 2022. The effective interest rate on the Notes is 4.72%.
-14-

Table of Contents
The Notes are unsecured senior obligations of the Company and rank equally in right of payment to all of its existing and future senior unsecured debt and senior in right of payment to all of its future subordinated debt.
The Notes will be redeemable at the Company’s option, in whole or in part, at any time on or after October 1, 2024, at a redemption price if redeemed during the 12 months beginning (i) October 1, 2024 of 102.250%, (ii) October 1, 2025 of 101.125%, and (iii) October 1, 2026 and thereafter of 100.000%, in each case of the principal amount of the Notes being redeemed, and together with accrued and unpaid interest, if any, to, but excluding, the date of redemption. The Company may also redeem some or all of the Notes before October 1, 2024 at a redemption price equal to 100% of the principal amount of the Notes, plus the applicable “make-whole” premium as of, and accrued and unpaid interest, if any, to, but excluding, the date of redemption. In addition, at any time prior to October 1, 2024, the Company may redeem up to 40% of the aggregate principal amount of the Notes issued under the Indenture on one or more occasions in an aggregate amount equal to the net cash proceeds of one or more equity offerings at a redemption price equal to 104.500% of the principal amount of the Notes redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption. Furthermore, the Company may be required to make an offer to purchase the Notes upon the sale of certain assets or upon specific kinds of changes of control.
The Indenture contains covenants that impose significant operational and financial restrictions on the Company; however, these covenants generally align with the covenants contained in the Credit Agreement. See "Credit Agreement" below for a description of these covenants.
Credit Agreement
On October 8, 2021, the Company entered into a new credit agreement (the “Credit Agreement”) among the Company, as borrower, each lender from time to time party thereto (the “Lenders”), JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “Agent”) and the Swing Line Lender (as defined in the Credit Agreement), and each L/C Issuer (as defined therein) party thereto, pursuant to which the Company established:
(i)       a five-year senior secured term loan A facility (the “Term Loan Facility”), in an aggregate principal amount of $350.0 million, the proceeds of which were used to refinance the Company’s existing senior secured credit facility as described below (the “Refinancing”), to pay fees and expenses incurred in connection with the Refinancing and the establishment of the Credit Facilities (as defined below) and for working capital and general corporate purposes of the Company and its subsidiaries, including the financing of acquisitions and other investments; and
(ii)     a five-year senior secured revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Credit Facilities”), in an aggregate principal amount of up to $1.0 billion (with a $25 million sub-limit for the issuance of letters of credit), the proceeds of which may be used for working capital and general corporate purposes of the Company and its subsidiaries, including the financing of acquisitions and other investments.
Subject to the terms and conditions set forth in the Credit Agreement (including obtaining additional commitments from one or more new or existing lenders), the Company may in the future incur additional loans or commitments under the Credit Agreement in an aggregate principal amount of up to $300 million, plus an additional amount so long as the Company’s pro forma First Lien Net Leverage Ratio (as defined in the Credit Agreement) would not exceed 3.85 to 1.00 as of the date such loans or commitments are incurred.
Borrowings under the Credit Facilities bear interest at an annual rate equal to, at the option of the Company, either (i) LIBOR (adjusted for reserves) plus a margin ranging from 1.25% to 2.25% or (ii) an alternate base rate plus a margin ranging from 0.25% to 1.25%, with the applicable margin determined by reference to a leverage-based pricing grid set forth in the Credit Agreement. As of October 31, 2021, the stated interest rate was 1.88% and the effective interest rate was 2.63%. The Company is also required to pay certain fees to the Lenders, including, among others, a quarterly commitment fee on the average unused amount of the Revolving Credit Facility at a rate ranging from 0.20% to 0.40%, with the applicable rate also determined by reference to a leverage-based pricing grid set forth in the Credit Agreement.
The loans made under the Term Loan Facility will amortize in equal quarterly installments in an aggregate annual amount equal to the following percentage of the original principal amount of the Term Loan Facility: (i) 2.5% for the first year after October 8, 2021; (ii) 5.0% for each of the second and third years after October 8, 2021; (iii) 7.5% for the fourth year after October 8, 2021; and (iv) 10.0% for the fifth year after October 8, 2021. In addition, the Term Loan Facility is required to be mandatorily prepaid with 100% of the net cash proceeds of all asset sales, insurance and condemnation recoveries, subject to customary exceptions and thresholds, including to the extent such proceeds are reinvested in assets useful in the business of the Company and its subsidiaries within 450 days following receipt (or committed to be reinvested within such 450-day period and reinvested within 180 days after the
-15-

Table of Contents
end of such 450-day period). The loans under the Credit Facilities may be prepaid, and the commitments thereunder may be reduced, by the Company without penalty or premium, subject to the reimbursement of customary “breakage costs.”
The Credit Agreement contains customary affirmative and negative covenants, including covenants that limit, among other things, the ability of the Company and its subsidiaries to incur additional indebtedness, create liens, merge or dissolve, make investments, dispose of assets, engage in sale and leaseback transactions, make distributions and dividends and prepayments of junior indebtedness, engage in transactions with affiliates, enter into restrictive agreements, amend documentation governing junior indebtedness, modify its fiscal year and modify its organizational documents, in each case, subject to customary exceptions, thresholds, qualifications and “baskets.” In addition, the Credit Agreement contains financial performance covenants, which require the Company to maintain (i) a maximum total net leverage ratio, measured as of the last day of each fiscal quarter, of no greater than 5.00 to 1.00 beginning with the fiscal quarter ending January 31, 2022, and (ii) a minimum consolidated interest coverage ratio, measured as of the last day of each fiscal quarter, of no less than 3.00 to 1.00 beginning with the fiscal quarter ending January 31, 2022. The Company was in compliance with all covenants under the Credit Agreement as of October 31, 2021, and for the period then ended.
The repayment obligation under the Credit Agreement may be accelerated upon the occurrence of an event of default thereunder, including, among other things, failure to pay principal, interest or fees on a timely basis, material inaccuracy of any representation or warranty, failure to comply with covenants, cross-default to other material debt, material judgments, change of control and certain insolvency or bankruptcy-related events, in each case, subject to any certain grace and/or cure periods.
The obligations of the Company under the Credit Agreement are required to be unconditionally guaranteed by each of the Company’s existing or subsequently acquired or organized direct and indirect domestic subsidiaries and are secured by security interests in substantially all assets of the Company and the guarantors, in each case, subject to certain customary exceptions.
Prior Credit Agreement
On August 30, 2019, the Company entered into a credit agreement (the "Prior Credit Agreement”) that provided for:
(i)       a five-year senior secured term loan A facility (the “Prior Term Loan Facility”), in an aggregate principal amount of $1.25 billion; and
(ii)      a five-year senior secured revolving credit facility (the “Prior Revolving Credit Facility” and, together with the Prior Term Loan Facility, the “Prior Credit Facilities”), in an aggregate principal amount of up to $350.0 million. No amounts were drawn under the Prior Revolving Credit Facility.
Borrowings under the Prior Credit Facilities bore interest at an annual rate equal to, at the option of HealthEquity, either (i) LIBOR (adjusted for reserves) plus a margin ranging from 1.25% to 2.25% or (ii) an alternate base rate plus a margin ranging from 0.25% to 1.25%, with the applicable margin determined by reference to a leverage-based pricing grid set forth in the Prior Credit Agreement. The Company was also required to pay certain fees to the lenders, including, among others, a quarterly commitment fee on the average unused amount of the Prior Revolving Credit Facility at a rate ranging from 0.20% to 0.40%, with the applicable rate also determined by reference to a leverage-based pricing grid set forth in the Prior Credit Agreement.
The Prior Credit Agreement contained customary affirmative and negative covenants, including covenants that limited, among other things, the ability of the Company to incur additional indebtedness, create liens, merge or dissolve, make investments, dispose of assets, engage in sale and leaseback transactions, make distributions and dividends and prepayments of junior indebtedness, engage in transactions with affiliates, enter into restrictive agreements, amend documentation governing junior indebtedness, modify its fiscal year and modify its organizational documents, in each case, subject to customary exceptions, thresholds, qualifications and “baskets.” In addition, the Prior Credit Agreement contained financial performance covenants, which required the Company to maintain (i) a maximum total net leverage ratio, measured as of the last day of each fiscal quarter, of no greater than 4.50 to 1.00 (subject to a customary “acquisition holiday” provision that allows the maximum total net leverage ratio to increase to 5.00 to 1.00 for the four fiscal quarter period ending on or following the date of a permitted acquisition by the Company in excess of $100.0 million), and (ii) a minimum interest coverage ratio, measured as of the last day of each fiscal quarter, of no less than 3.00 to 1.00. The Company was in compliance with all covenants under the Prior Credit Agreement during the period ended October 31, 2021.
The obligations of HealthEquity under the Prior Credit Agreement were required to be unconditionally guaranteed by WageWorks and Fort Effect Corp and were secured by security interests in substantially all assets of HealthEquity and the guarantors, subject to certain customary exceptions.
-16-

Table of Contents
On October 8, 2021, in connection with the entry into the Credit Agreement, the Company repaid all outstanding obligations under the Prior Credit Agreement and terminated all commitments thereunder.
Note 9. Stock-based compensation
The following table shows a summary of stock-based compensation in the Company's condensed consolidated statements of operations and comprehensive income (loss) during the periods presented:
Three months ended October 31,Nine months ended October 31,
(in thousands)2021202020212020
Cost of revenue$3,076 $2,209 $8,547 $5,737 
Sales and marketing829 2,035 5,677 4,810 
Technology and development3,458 2,641 10,164 8,051 
General and administrative5,921 4,594 17,312 11,715 
Other expense (1)  342  
Total stock-based compensation expense$13,284 $11,479 $42,042 $30,313 
(1)Equity-based awards exchanged for cash in connection with the Luum Acquisition.
Stock award plans
Incentive Plan. The Company grants stock options, restricted stock units ("RSUs"), and restricted stock awards ("RSAs") under the HealthEquity, Inc. 2014 Equity Incentive Plan (as amended and restated, the "Incentive Plan"), which provided for the issuance of stock awards to the directors and team members of the Company to purchase up to an aggregate of 2.6 million shares of common stock.
In addition, under the Incentive Plan, the number of shares of common stock reserved for issuance under the Incentive Plan automatically increases on February 1 of each year, beginning as of February 1, 2015 and continuing through and including February 1, 2024, by 3% of the total number of shares of the Company’s capital stock outstanding on January 31 of the preceding fiscal year, or a lesser number of shares determined by the board of directors. As of October 31, 2021, 7.5 million shares were available for grant under the Incentive Plan.
Stock options
A summary of stock option activity is as follows:
Outstanding stock options
(in thousands, except for exercise prices and term)Number of
options
Range of
exercise
prices
Weighted-
average
exercise
price
Weighted-
average
contractual
term
(in years)
Aggregate
intrinsic
value
Outstanding as of January 31, 20211,674 
$1.25 - 82.39
$31.46 5.0$87,164 
Exercised(280)
$1.25 - 44.53
$22.36 
Outstanding as of October 31, 20211,394 
$1.25 - 82.39
$33.29 4.2$47,032 
Vested and expected to vest as of October 31, 20211,394 $33.29 4.2$47,032 
Exercisable as of October 31, 20211,303 $30.76 4.0$46,863 
Restricted stock units and restricted stock awards
A summary of RSU and RSA activity is as follows:
RSUs and PRSUsRSAs and PRSAs
(in thousands, except weighted-average grant date fair value)SharesWeighted-average grant date fair valueSharesWeighted-average grant date fair value
Outstanding as of January 31, 20211,832 $60.41 193 $61.77 
Granted1,381 71.61   
Vested(418)58.09 (116)61.77 
Forfeited(255)62.99 (75)61.77 
Outstanding as of October 31, 20212,540 $66.62 2 $61.72 
-17-

Performance restricted stock units. During the first quarter of fiscal year 2022, the Company awarded 249,750 performance restricted stock units ("PRSUs") subject to a market condition based on the Company’s total shareholder return ("TSR") relative to the Russell 2000 index as measured on January 31, 2024. The Company used a Monte Carlo simulation to determine that the grant date fair value of the awards was $22.4 million. Compensation expense is recorded if the service condition is met regardless of whether the market condition is satisfied. The market condition allows for a range of vesting from 0% to 200% based on the level of performance achieved. The PRSUs cliff vest upon approval by the Compensation Committee of the board of directors.
Note 10. Fair value
Fair value measurements are made at a specific point in time based on relevant market information. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Accounting standards specify a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect data obtained from independent sources, while unobservable inputs reflect the Company’s market assumptions. These two types of inputs have created the following fair value hierarchy:
Level 1—quoted prices in active markets for identical assets or liabilities;
Level 2—inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
Level 3—unobservable inputs based on the Company’s own assumptions.
Cash and cash equivalents are considered Level 1 instruments and are valued based on publicly available daily net asset values. The carrying values of cash and cash equivalents approximate fair values due to the short-term nature of these instruments.
The Notes are valued based upon quoted market prices and are considered Level 2 instruments because the markets in which the Notes trade are not considered active markets. As of October 31, 2021, the fair value of the Notes was $605.2 million.
The Term Loan Facility is considered a Level 2 instrument and recorded at book value in the Company's condensed consolidated financial statements. The Term Loan Facility reprices frequently due to variable interest rate terms and entails no significant changes in credit risk. As a result, the fair value of the Term Loan Facility approximates carrying value.
The Prior Term Loan Facility was considered a Level 2 instrument and recorded at book value in the Company's condensed consolidated financial statements. The Prior Term Loan Facility repriced frequently due to variable interest rate terms and entailed no significant changes in credit risk. As a result, the fair value of the Prior Term Loan Facility approximated carrying value.
The contingent consideration liability resulting from the Luum Acquisition was determined using a Monte Carlo valuation model based on Level 3 inputs. The estimate of fair value of the contingent consideration obligation required subjective assumptions to be made regarding revenue growth rates, discount rates, peer revenue volatilities, and probabilities assigned to various potential business result scenarios and was determined using probability assessments with respect to the likelihood of achieving certain revenue targets. The fair value measurement was based on inputs unobservable in the market and thus represented a level 3 measurement. On October 31, 2021, the Company entered into an amendment to the purchase agreement to pay $6.0 million in satisfaction of the contingent consideration liability, and accordingly, the liability was transferred out of Level 3 as it was no longer measured at fair value. For further information, see Note 3—Business combination.
The following table reconciles the change in the fair value of the contingent consideration during the period presented:
(in thousands)Carrying amount
Balance as of January 31, 2021$ 
Contingent consideration recognized at acquisition8,147 
Change in fair value recognized in the condensed consolidated statement of operations and comprehensive income (loss)(2,147)
Balance as of October 31, 2021$6,000 
-18-

Note 11. Subsequent events
In April 2021, the Company entered into a definitive agreement to acquire Further for $500 million. Further is a leading provider of HSA and other CDB administration services, with approximately 580,000 HSAs and $1.9 billion of HSA Assets. In September 2021, the terms of the acquisition were amended pursuant to two agreements: (1) an amended agreement to acquire Further (other than VEBA, as described below) for $455 million, which closed on November 1, 2021, and (2) an agreement to acquire all cash balances and investment assets included in any voluntary employee beneficiary association (“VEBA”) account that is funding a health reimbursement arrangement (either Section 501(c)(9) or Section 115 trusts) and all contracts related exclusively thereto, subject to satisfaction of certain customary closing conditions, for a maximum purchase price of $45 million, calculated based on the actual amount of VEBA assets transferred relative to the total amount of VEBA assets as of April 30, 2021. On December 3, 2021, the parties agreed to terminate the agreement to acquire the Further VEBA business. The initial accounting for the acquisition is incomplete, pending identification and measurement of the assets acquired and liabilities assumed.
On December 6, 2021, HealthEquity entered into a definitive agreement with Health Savings Administrators, L.L.C. (“HealthSavings”) to transition the custody of HealthSavings’ HSA portfolio to HealthEquity. The definitive agreement provides a $60 million purchase price for approximately $1.3 billion of HSA assets held in approximately 87,000 HSAs. Given that a significant portion of the HSA assets are currently invested, HealthSavings and HealthEquity are working closely to coordinate an in-kind transfer of most of the invested assets. The transition of HealthSavings’ HSAs to the HealthEquity platform is expected to be completed in the first quarter of fiscal 2023.
-19-

Item 2. Management’s discussion and analysis of financial condition and results of operations

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. The following discussion and analysis contains forward-looking statements that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. Statements that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements are often identified by the use of words such as, but not limited to, “anticipate,” “believe,” “can,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “seek,” “should,” “target,” “will,” “would” and similar expressions or variations intended to identify forward-looking statements. Such statements include, but are not limited to, statements concerning our ability to integrate the acquisition of Further, the impact of the ongoing COVID-19 pandemic on the Company, the anticipated synergies and other benefits of the acquisitions of WageWorks and Further, health savings accounts and other tax-advantaged consumer-directed benefits, tax and other regulatory changes, market opportunity, our future financial and operating results, our investment and acquisition strategy, our sales and marketing strategy, management’s plans, beliefs and objectives for future operations, technology and development, economic and industry trends or trend analysis, expectations about seasonality, opportunity for portfolio purchases and other acquisitions, operating expenses, anticipated income tax rates, capital expenditures, cash flows and liquidity. These statements are based on the beliefs and assumptions of our management based on information currently available to us. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those identified below, and those discussed in the section titled “Risk factors” included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021, this Quarterly Report on Form 10-Q, and our other reports filed with the SEC. Furthermore, such forward-looking statements speak only as of the date of this report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such events.

Overview
We are a leader and an innovator in providing technology-enabled services that empower consumers to make healthcare saving and spending decisions. We use our innovative technology to manage consumers' tax-advantaged health savings accounts ("HSAs") and other consumer-directed benefits ("CDBs") offered by employers, including flexible spending accounts and health reimbursement arrangements (“FSAs” and “HRAs”), and to administer Consolidated Omnibus Budget Reconciliation Act (“COBRA”), commuter and other benefits. As part of our services, we and our subsidiaries provide consumers with healthcare bill evaluation and payment processing services, personalized benefit information including information on treatment options and comparative pricing, access to remote and telemedicine benefits, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings.
The core of our offerings is the HSA, a financial account through which consumers spend and save long-term for healthcare expenses on a tax-advantaged basis. As of October 31, 2021, we administered 6.2 million HSAs, with balances totaling $16.4 billion, which we call HSA Assets. Also, as of October 31, 2021, we administered 7.1 million complementary CDBs. We refer to the aggregate number of HSAs and other CDBs that we administer as Total Accounts, of which we had 13.3 million as of October 31, 2021.
We reach consumers primarily through relationships with their employers, which we call Clients. We reach Clients primarily through a sales force that calls on Clients directly, relationships with benefits brokers and advisors, and integrated partnerships with a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan recordkeepers, which we call Network Partners.
We have increased our share of the growing HSA market from 4% in calendar year 2010 to 17% as of October 31, 2021, measured by HSA Assets. According to Devenir, we are the largest HSA provider by accounts and second largest by assets as of June 2021. In addition, we believe we are the largest provider of other CDBs. We seek to differentiate ourselves through our proprietary technology, product breadth, ecosystem connectivity, and service-
-20-

driven culture. Our proprietary technology allows us to help consumers optimize the value of their HSAs and other CDBs and gain confidence and skills in managing their healthcare costs as part of their financial security.
Our ability to assist consumers is enhanced by our capacity to securely share data in both directions with others in the health, benefits, and retirement ecosystems. Our commuter benefits offering also leverages connectivity to an ecosystem of mass transit, ride hailing, and parking providers. These strengths reflect our “DEEP Purple” culture of remarkable service to customers and teammates, achieved by driving excellence, ethics, and process into everything we do.
We earn revenue primarily from three sources: service, custodial, and interchange. We earn service revenue mainly from fees paid by Clients on a recurring per-account per-month basis. We earn custodial revenue mainly from HSA Assets held at our members’ direction in federally insured cash deposits, insurance contracts or mutual funds, and from investment of Client-held funds. We earn interchange revenue mainly from fees paid by merchants on payments that our members make using our physical payment cards and on our virtual payment system. See “Key components of our results of operations” for additional information on our sources of revenue, including the adverse impacts caused by the ongoing COVID-19 pandemic.
WageWorks Acquisition
On August 30, 2019, we completed the acquisition of WageWorks, Inc. (the "WageWorks Acquisition") and paid approximately $2.0 billion in cash to WageWorks stockholders, financed through net borrowings of approximately $1.22 billion under our prior term loan facility and approximately $816.9 million of cash on hand. As a result of the WageWorks Acquisition, WageWorks Inc. became a wholly owned subsidiary of HealthEquity, Inc.
The key strategy of the WageWorks Acquisition was to enable us to increase the number of our employer sales opportunities, the conversion of these opportunities to Clients, and the value of Clients in generating members, HSA Assets and complementary CDBs. WageWorks’ historic strength of selling to employers directly and through health benefits brokers and advisors complemented our distribution through Network Partners. With WageWorks’ CDB capabilities, we provide employers with a single partner for both HSAs and other CDBs, which is preferred by the vast majority of employers according to research conducted for us by Aite Group. For Clients that partner with us in this way, we believe we can produce more value by encouraging both CDB participants to contribute to HSAs and HSA-only members to take advantage of tax savings available through other CDBs. Accordingly, we believe that there are significant opportunities to expand the scope of services that we provide to our Clients.
We are continuing our multi-year integration effort that we expect will produce long-term cost savings and revenue synergies. We have identified opportunities of approximately $80 million in annualized ongoing net synergies to be achieved by the end of fiscal year 2022, of which approximately $75 million were achieved as of October 31, 2021. Furthermore, we anticipate generating additional revenue synergies over the longer-term as our combined distribution channels and existing client base take advantage of the broader service offerings and as we continue to drive member engagement. We estimate non-recurring costs to achieve these synergies of approximately $110 million resulting from investment in technology we use to provide our services, and to run our back-office systems, and from integration of technology, as well as rationalization of cost of operations. Merger integration expenses attributable to the WageWorks Acquisition are expected to be completed by the end of fiscal year 2022, with the exception of ongoing lease expense related to certain WageWorks offices that have been permanently closed, less any related sublease income. As of October 31, 2021, we had incurred a total of $104 million of non-recurring merger integration costs related to the WageWorks Acquisition.
Luum Acquisition
In March 2021, we bolstered our commuter offering by acquiring 100% of the outstanding capital stock of Fort Effect Corp, d/b/a Luum (the "Luum Acquisition") for an aggregate purchase price consisting of $50.2 million in cash and up to $20.0 million in contingent payments payable during the two-year period following the closing of the Luum Acquisition. On October 31, 2021, we entered into an amendment to the purchase agreement to pay $6.0 million in satisfaction of the contingent consideration liability. Luum provides employers with a suite of commute tools as well as real-time commute data, to help them design and implement flexible return-to-office and hybrid-workplace strategies and benefits.
Fifth Third Bank HSA portfolio acquisition
In April 2021, we entered into a definitive agreement with Fifth Third Bank, National Association ("Fifth Third"), to transition the custody of Fifth Third’s HSA portfolio to HealthEquity. On September 29, 2021, the transaction was closed, in which we paid a $60.8 million purchase price for a transfer of approximately 160,000 HSAs and
-21-

$491.0 million of HSA Assets. The agreement includes a mechanism to adjust the purchase price based on the amount of HSA Assets actually transferred.
Further Acquisition
In April 2021, we entered into a definitive agreement to acquire Further for $500 million. Further is a leading provider of HSA and other CDB administration services, with approximately 580,000 HSAs and $1.9 billion of HSA Assets. In September 2021, the terms of the acquisition were amended pursuant to two agreements: (1) an amended agreement to acquire Further (other than VEBA, as described below) for $455 million, which closed on November 1, 2021, and (2) an agreement to acquire all cash balances and investment assets included in any voluntary employee beneficiary association (“VEBA”) account that is funding a health reimbursement arrangement (either Section 501(c)(9) or Section 115 trusts) and all contracts related exclusively thereto, subject to satisfaction of certain customary closing conditions, for a maximum purchase price of $45 million, calculated based on the actual amount of VEBA assets transferred relative to the total amount of VEBA assets as of April 30, 2021. On December 3, 2021, the parties agreed to terminate the agreement to acquire the Further VEBA business.
HealthSavings HSA portfolio acquisition
On December 6, 2021, we entered into a definitive agreement with Health Savings Administrators, L.L.C. (“HealthSavings”) to transition the custody of HealthSavings’ HSA portfolio to HealthEquity. The definitive agreement provides a $60 million purchase price for approximately $1.3 billion of HSA assets held in approximately 87,000 HSAs. Given that a significant portion of the HSA assets are currently invested, HealthSavings and HealthEquity are working closely to coordinate an in-kind transfer of most of the invested assets. The transition of HealthSavings’ HSAs to the HealthEquity platform is expected to be completed in the first quarter of fiscal 2023.
Key factors affecting our performance
We believe that our future performance will be driven by a number of factors, including those identified below. Each of these factors presents both significant opportunities and significant risks to our future performance. See also "Results of operations - Revenue" for information relating to the ongoing COVID-19 pandemic and also the section entitled “Risk factors” included in our Annual Report on Form 10-K for the fiscal year ended January 31, 2021, this Quarterly Report on Form 10-Q, and our other reports filed with the SEC.
Structural change in U.S. health insurance
We derive revenue primarily from healthcare-related saving and spending by consumers in the U.S., which are driven by changes in the broader healthcare industry, including the structure of health insurance. The average premium for employer-sponsored health insurance has risen by 22% since 2016 and 47% since 2011, resulting in increased participation in HSA-qualified health plans and HSAs and increased consumer cost-sharing in health insurance more generally. We believe that continued growth in healthcare costs and related factors will spur continued growth in HSA-qualified health plans and HSAs and may encourage policy changes making HSAs or similar vehicles available to new populations such as individuals in Medicare. However, the timing and impact of these and other developments in U.S. healthcare are uncertain. Moreover, changes in healthcare policy, such as "Medicare for all" plans, could materially and adversely affect our business in ways that are difficult to predict.
Trends in U.S. tax law
Tax law has a profound impact on our business. Our offerings to members, Clients, and Network Partners consist primarily of services enabled, mandated, or advantaged by provisions of U.S. tax law and regulations. Changes in tax policy are speculative, and may affect our business in ways that are difficult to predict.
Our client base
Our business model is based on a B2B2C distribution strategy, whereby we work with Network Partners and Clients to reach consumers to increase the number of our members with HSA accounts and complementary CDBs. We believe that there are significant opportunities to expand the scope of services that we provide to our current Clients.
Broad distribution footprint
We believe we have a diverse distribution footprint to attract new Clients and Network Partners. Our sales force calls on enterprise and regional employers in industries across the U.S., as well as potential Network Partners from among health plans, benefits administrators, and retirement plan record keepers.

-22-

Product breadth
We are the largest custodian and administrator of HSAs (by number of accounts), as well as a market-share leader in each of the major categories of complementary CDBs, including FSAs and HRAs, COBRA and commuter benefits administration. Our Clients and their benefits advisors increasingly seek HSA providers that can deliver an integrated offering of HSAs and complementary CDBs. With our CDB capabilities, we can provide employers with a single partner for both HSAs and complementary CDBs, which is preferred by the vast majority of employers, according to research conducted for us by Aite Group. We believe that the combination of HSA and complementary CDB offerings significantly strengthens our value proposition to employers, health benefits brokers and consultants, and Network Partners as a leading single-source provider.
Our proprietary technology
We believe that innovations incorporated in our technology, which enable us to better assist consumers to make healthcare saving and spending decisions and maximize the value of their tax-advantaged benefits, differentiate us from our competitors and drive our growth. We built on these innovations by combining our HSA offering with WageWorks' complementary CDB offerings, giving us a full suite of CDB products, and adding to our solutions set and leadership position within the HSA sector. We intend to continue to invest in our technology development to enhance our capabilities and infrastructure, while maintaining a focus on data security and the privacy of our customers' data. For example, we are making significant investments in the architecture and infrastructure of the technology that we use to provide our services to improve our transaction processing capabilities and support continued account and transaction growth, as well as in data-driven personalized engagement to help our members spend less, save more, and build wealth for retirement.
Our “DEEP Purple” service culture
The successful healthcare consumer needs education and guidance delivered by people as well as by technology. We believe that our "DEEP Purple" culture, which we define as driving excellence, ethics, and process while providing remarkable service, is a significant factor in our ability to attract and retain customers and to address nimbly, opportunities in the rapidly changing healthcare sector. We make significant efforts to promote and foster DEEP Purple within our workforce. We invest in and intend to continue to invest in human capital through technology-enabled training, career development, and advancement opportunities.
Interest rates
As a non-bank custodian, we contract with federally insured banks and credit unions, which we collectively call our Depository Partners, and also with insurance company partners, to hold custodial cash assets on behalf of our members. We earn a material portion of our total revenue from interest paid to us by these partners. Custodial cash assets held by our insurance company partners are held in group annuity contracts and similar arrangements. The lengths of our agreements with Depository Partners typically range from three to five years and may have fixed or variable interest rate terms. The terms of new and renewing agreements with our Depository Partners may be impacted by the then-prevailing interest rate environment, which in turn is driven by macroeconomic factors and government policies over which we have no control. Such factors, and the response of our competitors to them, also determine the amount of interest retained by our members. We believe that diversification of Depository Partners and insurance company partners, varied contract terms and other factors reduce our exposure to short-term fluctuations in prevailing interest rates and mitigate the short-term impact of sustained increases or declines in prevailing interest rates on our custodial revenue. Over longer periods, sustained shifts in prevailing interest rates affect the amount of custodial revenue we can realize on custodial assets and the interest retained by our members.
Although interest rates have improved somewhat, we expect our custodial revenue to continue to be adversely affected by the interest rate cuts by the Federal Reserve associated with the ongoing COVID-19 pandemic, the lack of demand from Depository Partners for deposits, and other market conditions that have caused the interest rates offered by our Depository Partners to decline significantly.
Interest on our five-year senior secured term loan A facility (the “Term Loan Facility”) changes frequently due to variable interest rate terms, and as a result, our interest expense is expected to fluctuate based on changes in prevailing interest rates.
Our competition and industry
Our direct competitors are HSA custodians and other CDB providers. Many of these are state or federally chartered banks and other financial institutions for which we believe benefits administration services are not a core business. Some of our direct competitors (including healthcare service companies such as United Health Group's Optum, Webster Bank, and well-known retail investment companies, such as Fidelity Investments) are in a position to
-23-

devote more resources to the development, sale, and support of their products and services than we have at our disposal. In addition, numerous indirect competitors, including benefits administration service providers, partner with banks and other HSA custodians to compete with us. Our Network Partners may also choose to offer competitive services directly, as some health plans have done. Our success depends on our ability to predict and react quickly to these and other industry and competitive dynamics.
As a result of the COVID-19 pandemic, we have seen an adverse impact on sales opportunities, with some opportunities delayed and most now being held virtually. We have seen a significant decline in the use of commuter benefits due to many of our members working from home during the outbreak or other impacts from the outbreak, which has negatively impacted both our interchange revenue and service revenue, and this "work from home" trend may continue after the pandemic. We have also seen a decline in interchange revenue across all other products. The extent to which the COVID-19 pandemic will negatively impact our business remains highly uncertain and cannot be accurately predicted.
Regulatory environment
Federal law and regulations, including the Affordable Care Act, the Internal Revenue Code, the Employee Retirement Income Security Act and Department of Labor regulations, and public health regulations that govern the provision of health insurance and provide the tax advantages associated with our serv